Table of Contents
Print

What research is being done on new treatments for ADHD Combined Type? 

Ongoing research is expanding beyond traditional medication into innovative approaches that target core ADHD symptoms, especially emotional regulation and impulsivity.New studies are exploring digital therapeutics, non-stimulant medications, and group-based strategies to redefine ADHD therapy. 

Cutting-Edge Treatment Innovations 

Researchers are exploring cutting-edge treatments such as digital tools, non-stimulant medication, and group therapies to enhance the way we manage ADHD Combined Type. 

Digital therapeutic video games 

EndeavorRx (AKL‑T01) is an FDA-cleared digital game designed to improve attention and inhibitory control. Trials in children and adults have demonstrated measurable benefits in objective attention metrics, both on and off medication  

AI-powered digital cognitive programs 

Recent randomized controlled trials show that AI-guided interventions can significantly reduce impulsivity and inattention by training brain function in real-time. 

Next-generation non-stimulant medications 

Research is advancing with drugs like guanfacine, targeting emotional reactivity and attention through brain-specific mechanisms strengthening emotional regulation and reducing impulsive responses. 

Neurofeedback and biofeedback techniques 

Neurofeedback uses EEG or fMRI feedback to retrain brain activity. While protocols vary, initial evidence indicates improvements in focus, emotional control, and executive functioning.  

Group-based psychoeducational and emotion-training programmes 

Pilot programmes that bring together support groups, parental involvement, and CBT have shown encouraging results in helping adolescents improve emotional regulation and interpersonal skills, though more robust trials are ongoing. 

These emerging options aim to complement medication, providing multi-modal ADHD therapy that addresses real-world challenges for individuals with Combined Type.For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Combined ADHD. 

Victoria Rowe, MSc, author for my patient advice - mypatientadvice.co.uk

Victoria Rowe, MSc

Author

Victoria Rowe is a health psychologist with a Master’s in Health Psychology and a BS in Applied Psychology. She has experience as a school psychologist, conducting behavioural assessments, developing individualized education plans (IEPs), and supporting children’s mental health. Dr. Rowe has contributed to peer-reviewed research on mental health, including studies on anxiety disorders and the impact of COVID-19 on healthcare systems. Skilled in SPSS, Minitab, and academic writing, she is committed to advancing psychological knowledge and promoting well-being through evidence-based practice.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Dr. Rebecca Fernandez, MBBS, author and a reviewer for my patient advice - mypatientadvice.co.uk

Dr. Rebecca Fernandez, MBBS

Reviewer

Dr. Rebecca Fernandez is a UK-trained physician with an MBBS and experience in general surgery, cardiology, internal medicine, gynecology, intensive care, and emergency medicine. She has managed critically ill patients, stabilised acute trauma cases, and provided comprehensive inpatient and outpatient care. In psychiatry, Dr. Fernandez has worked with psychotic, mood, anxiety, and substance use disorders, applying evidence-based approaches such as CBT, ACT, and mindfulness-based therapies. Her skills span patient assessment, treatment planning, and the integration of digital health solutions to support mental well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewer's privacy.